Prosetta Biosciences
PrivateLast Round
Series D
Dec 3, 2015
Total Funding Raised
$35.58M
Momentum Score
25 /100
Company Overview
Prosetta Biosciences is a biotechnology company focused on developing small-molecule antiviral therapeutics and advancing drug discovery for various human diseases through partnerships in oncology, neurodegenerative diseases, and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prosetta Biosciences Comps
Public and private peers based on sector, stage, and business model.
Prosetta Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 3, 2015 | ||||
| Series B | Jul 19, 2012 | ||||
| Grant | Jun 8, 2012 | ||||
| Series A | May 18, 2007 |
Key People
Founding team and executive leadership
Prosetta Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alger | Series D |
Prosetta Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Prosetta Biosciences's valuation, stock price, and market status.
